Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852000 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Radiomics for Distinguishing Benign and Malignant Lung Nodules

StatusNot Yet Recruiting
PhaseNot specified
Started2026-10
View on ClinicalTrials.gov ↗
1,604 trials monitored
See 18 trials at risk
4,033 trials monitored
See 210 trials at risk
Differentiating between benign (non-cancerous) and malignant (cancerous) pulmonary nodules is a critical step in determining appropriate patient management and cancer treatment planning. Conventional evaluation using chest computed tomography (CT) relies on visual inspection of features such as size, shape, and borders; however, benign and malignant nodules frequently exhibit overlapping characteristics, which often necessitates invasive biopsy procedures. Radiomics is an emerging analytical technique that extracts high-dimensional quantitative data from standard medical images, including tissue texture, density patterns, and complex spatial features, that cannot be detected by visual inspection alone. The purpose of this observational study is to evaluate the utility of CT-derived radiomics combined with machine learning algorithms to non-invasively differentiate between benign and malignant pulmonary nodules. Researchers will extract quantitative imaging features from chest CT scans of patients presenting with pulmonary nodules measuring less than 5 cm to train and validate predictive machine learning models, with the goal of improving non-invasive diagnostic accuracy and reducing unnecessary biopsy procedures.
Trial Details
NCT Number NCT07852000
Lead Sponsor Assiut University
Conditions Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules
Enrollment 255 participants
Start Date 2026-10
Primary Completion 2027-10 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-10-01